Prof. Meshorer’s election carries special resonance at a time when Israel’s scientific community continues to thrive amid considerable societal and geopolitical challenges. According to Prof. Tamir Sheafer, Rector of The Hebrew University, this recognition is not merely an individual accolade but a testament to the university’s dedication to scientific excellence and innovation. The election highlights the resilience and global reach of Hebrew University researchers, showcasing their ability to conduct impactful, cutting-edge science that transcends borders and politics.

The scientific heart of Prof. Meshorer’s research lies in unraveling the epigenetic mechanisms that govern chromatin structure and dynamics, particularly in embryonic stem cells. His laboratory explores how the plasticity of chromatin—the complex of DNA and proteins within the cell nucleus—regulates gene expression programs essential for stem cell pluripotency, differentiation pathways, and ultimately, cell fate decisions. This realm of biology is vital for understanding how a single genome can produce the diverse cell types required during development and tissue homeostasis.

Diving deeper into chromatin biology, Prof. Meshorer’s work elucidates the intricate relationship between histone modifications, DNA methylation, and nucleosome positioning, which together orchestrate the accessibility of genetic information for transcriptional machinery. By applying state-of-the-art genomic technologies, including single-cell epigenomics and chromatin conformation assays, his group maps dynamic changes in chromatin landscapes during neuronal differentiation and in stem cell models of neurodegenerative diseases. These insights are pivotal for uncovering how epigenetic regulation can go awry in pathological states.

One of the hallmarks of Prof. Meshorer’s contribution is the interdisciplinary approach combining molecular genetics, cell biology, and computational genomics. His lab’s discoveries on the maintenance of pluripotency via chromatin remodeling complexes offer compelling evidence of epigenetic flexibility as a cornerstone of stem cell biology. These molecular pathways hold significant promise for regenerative medicine, as modulating epigenetic states could enable controlled differentiation of stem cells into desired lineages, presenting therapeutic avenues for currently incurable neurological conditions.

Beyond classical epigenetics, Prof. Meshorer has notably co-pioneered the emerging field of paleo-epigenetics. By reconstructing DNA methylation patterns in archaic human genomes, including Neanderthals and Denisovans, his research provides unprecedented insight into evolutionary biology and the epigenetic basis of human adaptation. This innovative approach bridges modern molecular biology with anthropology, revealing how epigenetic modifications contributed to species-specific traits and evolutionary divergence.

Prof. Meshorer’s election to EMBO will enhance collaborative opportunities among the international life sciences community, fostering interdisciplinary research aimed at decoding complex biological systems. EMBO membership is awarded not only as a recognition of scientific excellence but also as an invitation to contribute actively to the advancement of molecular biology through joint initiatives, policy shaping, and mentoring young scientists worldwide.

In his own words, Prof. Meshorer expressed deep honor at joining EMBO, emphasizing that this recognition reflects both individual achievement and collective creativity borne from collaborative scientific environments. He anticipates engaging with EMBO’s mission to promote excellence and facilitate cross-border scientific interaction, which he views as essential for tackling the multifaceted challenges in biology and medicine.

The research paradigm championed by Prof. Meshorer addresses fundamental questions in developmental biology: How is genomic information dynamically regulated during cell state transitions? How do epigenetic landscapes sculpt cellular identity and function? His work significantly contributes to decoding the epigenetic language that mediates plasticity and stability within genomes, thus impacting fields ranging from neurobiology to regenerative therapeutics.

The translation of Prof. Meshorer’s findings into disease contexts is particularly impactful in neurodegenerative disorders, where epigenomic dysregulation may underlie pathological neuronal degeneration. By employing stem cell-derived neuronal models, his research elucidates molecular mechanisms that could be harnessed for interventions aiming to restore epigenetic balance and neuronal function, offering hope for new treatment strategies.

Moreover, Prof. Meshorer’s innovative use of high-resolution epigenetic profiling technologies sets benchmarks for future studies investigating chromatin dynamics. The refinement of these tools allows scientists to capture transient chromatin states and heterogeneous epigenetic landscapes at a single-cell level, thereby pushing forward our understanding of gene regulation in complex tissues and disease.

The Hebrew University lauds Prof. Meshorer’s achievement as emblematic of its enduring commitment to fostering world-class research that propels scientific frontiers. His election to EMBO not only honors his personal scientific journey but also shines a global spotlight on the vibrant life sciences ecosystem nurtured within Israeli academia.

As Prof. Meshorer steps into this new role within EMBO, the scientific community eagerly anticipates his continued contributions towards unraveling the epigenetic codes that govern development and disease. His work epitomizes the fusion of technical innovation and conceptual breakthroughs necessary to solve some of biology’s most challenging puzzles in the 21st century.

Subject of Research: Epigenetics, Chromatin Biology, Stem Cell Pluripotency, Neurodegenerative Diseases, Paleo-epigenetics

Article Title: Prof. Eran Meshorer Elected to EMBO for Groundbreaking Research in Epigenetics and Stem Cell Biology

News Publication Date: Information not provided

Web References: https://mediasvc.eurekalert.org/Api/v1/Multimedia/416529ae-d116-4492-adee-1c336ee69350/Rendition/low-res/Content/Public

Image Credits: Eviatar Klopstock

Keywords: Epigenetics, Chromatin, Stem cell research, Gene expression, Neurodegenerative diseases, Genome plasticity, Developmental biology

Chromatin remodeling is a fundamental process by which eukaryotic cells alter the structure of chromatin — the complex of DNA and histone proteins — thereby modulating access to the genetic code. Central to this process are ATP-driven molecular machines, including the Snf2 family of ATPases. Among them, SNF2H, a member of the ISWI (Imitation Switch) subfamily, has emerged as a pivotal regulator, yet the precise mechanisms by which it refines chromatin structure have remained largely mysterious until now.

The study meticulously dissects how SNF2H harnesses the energy derived from ATP hydrolysis to slide nucleosomes along DNA. This repositioning is not a random event; it requires highly coordinated structural transformations both within SNF2H and the nucleosome substrate. Cryo-electron microscopy combined with biochemical assays unveiled that SNF2H interacts with the nucleosome at distinct interfaces, translating ATP hydrolysis into mechanical force that repositions DNA around histone octamers.

One of the remarkable findings highlighted in the research is the conformational plasticity of SNF2H, which adjusts its structural domains in response to nucleosome engagement. This flexibility underscores a dynamic allosteric regulation mechanism that ensures efficient chromatin remodeling activity. The authors reveal that the interaction between SNF2H’s ATPase domain and the nucleosome’s DNA strongly influences the enzyme’s catalytic cycle, positioning SNF2H as a finely tuned molecular motor.

Further emphasizing the complexity, the team discovered that SNF2H-mediated sliding is tightly coupled with histone-DNA contacts. As SNF2H translocates DNA, it transiently destabilizes nucleosome wrapping, facilitating nucleosome mobilization without disassembly. This mechanism is crucial to maintain chromatin integrity while enabling access to specific genomic regions required for transcription, replication, and repair.

Intriguingly, the study also explores how SNF2H’s remodeling function is context-dependent, modulated by the presence of auxiliary protein factors and post-translational histone modifications. These modulators act as molecular signals that fine-tune SNF2H activity, ensuring precise remodeling patterns across different chromatin landscapes and cellular states. Such insights help explain how chromatin remodelers achieve selectivity amidst the complex nuclear environment.

At the molecular level, Malik and colleagues identified key residues within SNF2H’s ATPase domain that act as sensors for nucleotide binding and hydrolysis states. Mutagenesis experiments showed that altering these residues impairs the enzyme’s ability to couple ATP turnover with DNA translocation, confirming their essential role in chromatin remodeling. These findings pave the way for the development of small molecules targeting SNF2H activity, with potential implications for epigenetic therapies.

Another critical aspect revealed by the research is SNF2H’s ability to discriminate between different nucleosome substrates. The enzyme demonstrates a preference for nucleosomes with specific histone variant compositions and DNA sequences, reflecting a sophisticated recognition mechanism. This substrate specificity contributes to the precise spatial and temporal control of chromatin remodeling during cellular processes such as differentiation and stress responses.

Beyond fundamental biology, the study has profound implications for understanding disease mechanisms. Aberrant chromatin remodeling is implicated in cancers, neurodevelopmental disorders, and aging-related pathologies. By elucidating SNF2H’s remodeling mechanism, the current research offers a molecular framework to interpret how mutations or dysregulated expression of chromatin remodelers contribute to disease etiology.

The authors also discuss potential intersections between SNF2H activity and DNA damage repair pathways. Chromatin remodeling is a prerequisite for efficient repair by granting repair machinery access to damaged DNA. Understanding how SNF2H coordinates chromatin dynamics in response to DNA lesions could inform strategies to enhance genome stability in therapeutic contexts.

Methodologically, the study exemplifies the power of integrative structural biology, combining high-resolution cryo-EM, single-molecule biophysics, and in vitro reconstitution systems. This multi-pronged approach allowed the team to capture transient remodeling intermediates and elucidate the stepwise mechanism by which SNF2H mobilizes nucleosomes, setting a new standard for studying ATP-dependent chromatin remodelers.

The findings reported by Malik, Deshmukh, Bilokapic, and co-workers represent a landmark achievement in chromatin biology, offering a detailed molecular blueprint of SNF2H’s function. As chromatin remodeling continues to be recognized as a central determinant of gene regulation, this comprehensive mechanistic insight will inspire future research exploring how modulating remodeler activity can be harnessed for therapeutic benefit.

In conclusion, this seminal work not only demystifies the operational principles of a major chromatin remodeling ATPase but also underscores the intricate interplay between enzymatic motors and chromatin substrates. It sets the stage for innovative research at the intersection of structural biology, epigenetics, and disease, highlighting the transformative potential of targeting chromatin dynamics in medicine.

Subject of Research: Mechanisms of chromatin remodeling by the human Snf2-type ATPase SNF2H

Article Title: Mechanisms of chromatin remodeling by the human Snf2-type ATPase SNF2H

Article References:
Malik, D., Deshmukh, A., Bilokapic, S. et al. Mechanisms of chromatin remodeling by the human Snf2-type ATPase SNF2H. Cell Res (2025). https://doi.org/10.1038/s41422-025-01103-w

Image Credits: AI Generated